{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T12:06:18Z","timestamp":1725883578404},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s40618-020-01204-w","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T12:03:06Z","timestamp":1583323386000},"page":"1159-1161","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dominus effect: challenging complications of alemtuzumab-related thyroid autoimmunity"],"prefix":"10.1007","volume":"43","author":[{"given":"Assunta","family":"Bianco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Traini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Del Giacomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Del Gatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Lucchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo A.","family":"Rota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Mirabella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"1204_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s40618-019-01105-7","volume":"43","author":"L Scappaticcio","year":"2019","unstructured":"Scappaticcio L, Castellana M, Virili C, Bellastella G, Centanni M, Cannav\u00f2 S, Campenn\u00ec A, Ruggeri RM, Giovanella L, Trimboli P (2019) Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis. J Endocrinol Invest 43:219\u2013229","journal-title":"J Endocrinol Invest"},{"key":"1204_CR2","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1007\/s00415-018-8822-y","volume":"265","author":"V Devonshire","year":"2018","unstructured":"Devonshire V, Phillips R, Wass H, Da Roza G, Senior P (2018) Monitoring and management of autoimmunity in multiple sclerosis patients treated with alemtuzumab: practical recommendations. J Neurol 265:2494\u20132505","journal-title":"J Neurol"},{"key":"1204_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1136\/jnnp-2014-307721","volume":"86","author":"O Tuohy","year":"2015","unstructured":"Tuohy O, Costelloe L, Hill-Cawthorne G, Bjornson I, Harding K, Robertson N et al (2015) Alemtuzumab treatment of multiple sclerosis: long term safety and efficacy. J Neurol Neurosurg Psychiatry 86:208\u2013215","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1204_CR4","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1210\/jc.2018-00359","volume":"103","author":"N Pariani","year":"2018","unstructured":"Pariani N, Willis M, Muller I, Healy S, Nasser T, McGowan A et al (2018) Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features. J Clin Endocrinol Metab 103:3010\u20133018","journal-title":"J Clin Endocrinol Metab"},{"key":"1204_CR5","first-page":"765","volume":"26","author":"XG Vos","year":"2016","unstructured":"Vos XG, Endert E, Zwinderman K, Tijssen JGP, Wiersinga WM (2016) Predicting the risk of recurrence before the start of antithyroid drug therapy in patients with Graves\u2019 hyperthyroidism. J Clin Endocrinol Metab 26:765\u2013769","journal-title":"J Clin Endocrinol Metab"},{"key":"1204_CR6","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s40618-016-0516-7","volume":"39","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Masiello E, Magri F, Veronesi G, Bianconi E, Zerbini F, Gaiti M, Spreafico E, Gallo D, Premoli P, Piantanida E, Tanda ML, Ferrario M, Vitti P, Chiovato L (2016) The phenotype of newly diagnosed Graves\u2019 disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study. J Endocrinol Invest 39:1445\u20131451","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01204-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-020-01204-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01204-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T01:04:25Z","timestamp":1614819865000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-020-01204-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":6,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1204"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01204-w","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"assertion":[{"value":"3 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals,"}},{"value":"Informed consent was obtained by patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}